Anand A. Dalal, PhD, MBA

Articles by Anand A. Dalal, PhD, MBA

Outcomes Associated With Timing of Maintenance Treatment for COPD Exacerbation

ByAnand A. Dalal, PhD, MBA,Manan B. Shah, PharmD, PhD,Anna O. D'Souza, BPharm, PhD,Amol D. Dhamane, BPharm, MS,Glenn D. Crater, MD

September 14th 2012

Early initiation of maintenance medication in patients with moderate to severe COPD exacerbations is associated with reduced risk of future exacerbations and lower costs.

COPD-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenanc

ByAnand A. Dalal, PhD, MBA,Manan Shah, PhD,Anna O. D'Souza, PhD,Douglas W. Mapel, MD

March 16th 2011

Initiation of fluticasone propionate–salmeterol after a COPD-related hospitalization or ED visit decreased the risk of a recurrent event and reduced COPD-related medical costs.

Anand A. Dalal, PhD, MBA

Articles by Anand A. Dalal, PhD, MBA

Outcomes Associated With Timing of Maintenance Treatment for COPD Exacerbation

COPD-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenanc

Latest Updated Articles

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

US Employer Health Care Costs Projected to Rise 9.5% in 2027

Student Mental Health, Success Tied to Future Health and Affordability

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Mobile Integrated Health Valuable in Heart Failure, but Payment Lags